Article Details

COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook - Benzinga

Retrieved on: 2022-04-25 11:25:02

Tags for this article:

Click the tags to see associated articles and topics

COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook - Benzinga. View article details on hiswai:

Excerpt

Roche Holdings AG's · Ocrevus revenue gained 18% to reach CHF1.45 billion, and Hemlibra sales jumped 30% to CHF853 million, offsetting a decline in ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up